Inventor
ZHANG RUMIN
US21 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG RUMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
12 patentsUS5990276ANov 23, 1999
Synthetic inhibitors of hepatitis C virus NS3 protease
SCHERING CORP203 citations95
US6251583B1Jun 26, 2001
Peptide substrates for HCV NS3 protease assays
SCHERING CORP45 citations90
US5767233AJun 16, 1998
Soluble cleavable substrates of the hepatitis C virus protease
SCHERING CORP10 citations72
US6624290B2Sep 23, 2003
Azapeptides useful in the treatment of Hepatitis C
SCHERING CORP6 citations62
US7067273B2Jun 27, 2006
Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same
SCHERING CORP3 citations57
US8034907B2Oct 11, 2011
Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
SCHERING CORP0 citations49
US7632920B2Dec 15, 2009
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
SCHERING CORP0 citations49
US7446195B2Nov 4, 2008
High affinity thiophene-based and furan-based kinase ligands
SCHERING CORP1 citations49
US7888474B2Feb 15, 2011
HDM2 polypeptides
SCHERING CORP0 citations48
US7705127B1Apr 27, 2010
HDM2 Polypeptides
SCHERING CORP0 citations48
US7592315B2Sep 22, 2009
Peptide viral entry inhibitors
SCHERING CORP0 citations45
US7511063B2Mar 31, 2009
High affinity quinoline-based kinase ligands
SCHERING CORP0 citations39
JIANGSU HENGRUI MEDICINE CO
3 patentsUS12187684B2Jan 7, 2025
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof
JIANGSU HENGRUI MEDICINE CO0 citations61
US11512055B2Nov 29, 2022
Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof
JIANGSU HENGRUI MEDICINE CO1 citations61
US11332492B2May 17, 2022
CD73 inhibitors and therapeutic uses thereof
JIANGSU HENGRUI MEDICINE CO0 citations50